Neogenomics Inc $NEO

Recent News (17)

• Boya Launches Notra Neo at IFA 2026, Making Everyday AI Note-Taking More Accessible PR Newswire · 04 Sep 2026 BERLIN, Sept. 4, 2026 /PRNewswire/ -- Boya today announced the official launch of Boya Notra Neo, the newest AI note taker in the Notra lineup, at IFA 2026. Designed as a more accessible entry point t…
• Anortech Receives US$1.0 Million Cash and Shares from Sarfartoq Ree Project Transaction GlobeNewswire · 03 Sep 2026 VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- AnorTech Inc. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTCQB “ANORF”) is pleased to announce that, the Company has …
• Cloover reaches profitability at $350M run-rate as it launches AI-native neo-utility PR Newswire · 01 Sep 2026 Profitable at a run rate of $350 million, and with more than $1.3 billion in financing capacity behind it, Cloover is extending from finance and software to energy to become an AI-native neo-utility w…
• Sigenergy เปิดตัว "SigenStor NEO" ในประเทศไทย นำเสนอโซลูชันพลังงานอัจฉริยะแบบครบวงจรรุ่นใหม่ GlobeNewswire · 29 Aug 2026 กรุงเทพฯ, Aug. 29, 2026 (GLOBE NEWSWIRE) -- Sigenergy เดินหน้าขยายธุรกิจโซลูชันพลังงานอัจฉริยะในประเทศไทย ด้วยการเปิดตัวอย่างเป็นทางการภายใต้ชื่องาน "Unfold the New Era of Energy Intelligence: Sigen…
• Sigenergy ra mắt "SigenStor NEO" tại Thái Lan, Giới thiệu giải pháp năng lượng thông minh tích hợp mới GlobeNewswire · 29 Aug 2026 BANGKOK, Aug. 29, 2026 (GLOBE NEWSWIRE) -- Sigenergy tiếp tục mở rộng hoạt động kinh doanh giải pháp năng lượng thông minh tại Thái Lan với sự kiện ra mắt chính thức "Mở ra kỷ nguyên mới của trí tuệ…
• Sigenergy Launches “SigenStor NEO” in Thailand, Introducing a New All-in-One Smart Energy Solution GlobeNewswire · 28 Aug 2026 BANGKOK, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Sigenergy continues to expand its smart energy solutions business in Thailand with the official launch of “Unfold the New Era of Energy Intelligence: Sigen…
• NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point Yahoo Finance · 27 Aug 2026 NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point
• NeoGenomics gains Medicare coverage for cancer MRD test Investing.com · 26 Aug 2026 NeoGenomics gains Medicare coverage for cancer MRD test
• NEO Launches NEO 2.0, an AI-Powered Global Listing Service Built for New Construction PR Newswire · 25 Aug 2026 Rebuilt from the ground up, NEO 2.0 expands professional distribution and introduces a new generation of tools for builders, real estate professionals and homebuyers ORLANDO, Fla., Aug. 25, 2026 /PRNe…
• Neora Wins Gold at the 2026 Arte of Beauty Awards for Best Anti-Aging Product with Neo-FILLER Lift + Fill Corrective Elixir PR Newswire · 25 Aug 2026 DALLAS, Aug. 25, 2026 /PRNewswire/ -- The 2026 Arte of Beauty Awards and the International Awards Associate (IAA) have named Neora a Gold winner for product innovation for its Neo-FILLER Lift + Fill C…
• Nuix FY26 slides: Neo platform drives 179% ACV surge, profit jumps 60% Investing.com · 24 Aug 2026 Nuix FY26 slides: Neo platform drives 179% ACV surge, profit jumps 60%
• Nuix FY26 slides: Neo platform drives 179% ACV surge, stock jumps 21% Investing.com · 24 Aug 2026 Nuix FY26 slides: Neo platform drives 179% ACV surge, stock jumps 21%
• Cerebras Sees Neo-Clouds Breaking Away From NVIDIA Dependence — Calls 2027 Opportunity ‘Large’ Yahoo Finance · 13 Aug 2026 Cerebras Sees Neo-Clouds Breaking Away From NVIDIA Dependence — Calls 2027 Opportunity ‘Large’
• MCD Stock Price and Chart — NEO:MCD TradingView · 04 Aug 2026 MCD Stock Price and Chart — NEO:MCD  TradingView
• UNCOMMON PRODUCTIONS & CITIZEN56 ANNOUNCE 7-CITY NATIONAL TOUR OF THE POISONER PR Newswire · 03 Aug 2026 Neo-Noir Thriller Inspired by the Flint Water Crisis Written by M.M. Haney | Developed and Directed by Two-Time Obie Award Winner Lee Sunday Evans Tour Runs September 17 – October 31, 2026 BOSTON, Aug…
• How Apple’s cheap MacBook Neo sparked a war in budget laptops MarketWatch · 02 Aug 2026 Apple’s gamble on the budget MacBook Neo is paying off and forcing rivals to rethink their offerings.
• Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026 GlobeNewswire · 24 Jul 2026 SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune disease…